Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

STEMCELL Technologies Anti-Human CD326 (EpCAM) Antibody, Clone 323/A3, Size: 100 µg
SDP

Supplier:  STEMCELL Technologies 60146

Encompass_Preferred

Clone 323/A3 is a mouse monoclonal antibody that reacts with the human epithelial cell adhesion molecule (CD326), an ~40 kDa type I transmembrane glycoprotein which functions as a homophilic and Ca++-independent adhesion molecule. Verified for use with flow cytometry and immunohistochemistry assays, use this antibody in applications requiring the detection of human CD326 (EpCAM). EpCAM has roles in several cellular processes, including signaling, migration, proliferation, and differentiation. It is expressed early during erythrogenesis and has been identified as a stem cell marker. The protein is found on the basolateral membrane of most normal epithelial cells and is highly expressed in bone marrow, colon, and lung. EpCAM is not expressed on mesothelial cells or mesotheliomas, and so is used as a diagnostic marker to distinguish mesothelioma and carcinoma cells, as well as serving as a target for immunotherapeutic treatment of carcinomas. Visit STEMCELL.com for more information.

Catalog No. 50-197-5722


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.